Smart packaging could improve how older adults take medication

Translate to Spanish or other 102 languages!

Smart packages are used to electronically monitor when patients take their medication. When the prescription is not followed as advised by their physician the smart system can notify patients and their caregivers. Image for illustration purposes
Smart packages are used to electronically monitor when patients take their medication. When the prescription is not followed as advised by their physician the smart system can notify patients and their caregivers. Image for illustration purposes

Mega Doctor News

- Advertisement -

By University of Waterloo

Newswise — Older adults are open to using smart packaging to improve their medication-taking experience, a new study finds.

Smart packages are used to electronically monitor when patients take their medication. When the prescription is not followed as advised by their physician the smart system can notify patients and their caregivers. 

- Advertisement -

Approximately half of the patients with chronic diseases in developed nations do not take their medication properly. With an aging population where taking multiple medications is common, incorrect medication-taking – called medication non-adherence – is a problem impacting the health of patients and costs the healthcare system billions of dollars.

There has been a surge of telehealth technology to address this issue in the last two decades, from complex at-home medication dispensing devices to reminder apps. 

“Many of these products are advertised as user-friendly and efficient, but not all are tested with seniors in mind. So how would we know if older adults are able to use them for their day-to-day medication intake and are there any factors that can impact their in-home utilization?” said Sadaf Faisal, a PhD candidate at the University of Waterloo School of Pharmacy and lead author of the study. 

The researchers visited and studied 10 participants in their homes with a mean age of 76. On average, each took 11 medications for at least five chronic diseases. The participants were provided with a smart blister pack that synchronized with a web portal and recorded each time a participant opened a blister to take medications. 

- Advertisement -

The researchers then interviewed the participants to assess their experience with the smart blister package. They were also asked to rank the usability of the technology against standardized scales used in product assessment.

“Across participants, we found fairly consistent pros and cons to the technology,” said Tejal Patel, a pharmacy professor and co-author of the study. “The ability to learn the product easily was important for the participants to use it consistently. Feedback from their social circle – such as supportive children, partners or health-care providers – also helped reinforce using the technology.”

In general, participants who were more comfortable with technology were more open to using and liking the smart blister pack. However, device size and lack of portability were a significant downside, and if the product behaved inconsistently – sending reminders one day but not another, for example – participants became frustrated. Participants also said cost was a barrier to use and that they would be less likely to consider smart technology if it was not covered by a drug plan or funded by the government.

“For technology to be effective, it has to be accepted by the end-users,” Faisal said. “Smart, technology-based adherence products have the potential to support patients, but health-care providers should assess older adults’ medication intake behaviors and barriers and facilitators to using a product before recommending them.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

AMA Advises Patients to Check with Doctors on Web Advice

The internet offers no shortage of health advice. But with misleading medical claims spread across social media, search engines, and AI platforms, finding trustworthy answers can be a challenge. 

FDA Authorizes Focused Ultrasound Treatment for Varicose Veins

Theraclion has announced that the US Food and Drug Administration (FDA) has granted De Novo authorization for its Sonovein device to treat superficial venous reflux in great saphenous veins (GSV), the main cause of varicose veins. This is the first noninvasive focused ultrasound platform to treat varicose veins, which affect approximately one third of adults.

Identify the Early Warning Signs of Memory Loss

We’ve all lost our keys or forgotten a name every now and then, but when does forgetfulness signal something more serious?

Renaissance Cancer Foundation to Host 16th Anniversary “Viva la Vida” Gala, Nov. 21st

 The Renaissance Cancer Foundation, a non-profit organization of DHR Health, is excited to announce its 16th anniversary gala, featuring Miami’s premier party band, Extasy. The fundraising event is set to take place on November 21, 2026, at the Edinburg Conference Center at Renaissance, located at 118 Paseo Del Prado in Edinburg.
- Advertisement -